Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy?

Literature DB >> 23483438

Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy?

Christopher Bierton¹, Neil E I Langlois.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23483438 DOI： 10.1007/s12024-013-9412-z

Source DB: PubMed Journal: Forensic Sci Med Pathol ISSN： 1547-769X Impact factor: 2.007

× No keyword cloud information.

9 in total

1. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.

Authors: F Puisieux; P de Groote; E Masy; C Di Pompeo; A Millaire; O Bouillanne; B Jude; P Dewailly; G Ducloux
Journal: Am J Med Date: 2000-12-01 Impact factor: 4.965

2. Antiphospholipid antibodies.

Authors: Caron P Misita; Stephan Moll
Journal: Circulation Date: 2005-07-19 Impact factor: 29.690

3. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors: S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal: J Thromb Haemost Date: 2006-02 Impact factor: 5.824

4. Primary antiphospholipid syndrome in monozygotic twins.

Authors: V Ravindran; S Rajendran; G Elias
Journal: Lupus Date: 2012-11-15 Impact factor: 2.911

5. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease.

Authors: S Nityanand; C Bergmark; U de Faire; J Swedenborg; G Holm; A K Lefvert
Journal: J Intern Med Date: 1995-11 Impact factor: 8.989

6. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

Authors: G Finazzi; V Brancaccio; M Moia; N Ciaverella; M G Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; T Barbui
Journal: Am J Med Date: 1996-05 Impact factor: 4.965

Review 7. Review: antiphospholipid antibodies and the lung.

Authors: R A Asherson; R Cervera
Journal: J Rheumatol Date: 1995-01 Impact factor: 4.666

Review 8. Clinical and epidemiological aspects in the antiphospholipid syndrome.

Authors: Ricard Cervera; Ronald A Asherson
Journal: Immunobiology Date: 2003 Impact factor: 3.144

9. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.

Authors: K S Ginsburg; M H Liang; L Newcomer; S Z Goldhaber; P H Schur; C H Hennekens; M J Stampfer
Journal: Ann Intern Med Date: 1992-12-15 Impact factor: 25.391